{"id":"W2952175842","doi":"10.1097/01.hs9.0000559784.51441.da","title":"PF393 A RANDOMISED JOINT AUSTRALASIAN (ALLG) AND FRENCH (FILO) STUDY OF LENALIDOMIDE CONSOLIDATION IN PATIENTS WITH RESIDUAL CLL AFTER FRONT‐LINE TREATMENT WITH FC/FCR (THE CLL6 TRIAL)","year":2019,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nutrasource","funders":"","keywords":"Lenalidomide; Medicine; Minimal residual disease; Fludarabine; Internal medicine; Oncology; Progression-free survival; Cyclophosphamide; Chronic lymphocytic leukemia; Surgery; Leukemia; Chemotherapy; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001843213,0.001248996,0.001638603,0.0002849683,0.0003986923,0.00112267,0.0006309644,0.001808315,0.005080847],"category_scores_gemma":[0.001185691,0.0003697859,0.001606006,0.0003519266,0.0007617725,0.0007318628,0.0005449161,0.002559641,0.0007803876],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001548769,"about_ca_system_score_gemma":0.001646589,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002556482,"about_ca_topic_score_gemma":0.004269418,"domain_scores_codex":[0.9991118,0.000561436,0.00003131432,0.0001001588,0.00004681456,0.0001484294],"domain_scores_gemma":[0.9990276,0.0001481697,0.0001907537,0.00006513746,0.00006994451,0.000498409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9693614,0.005075429,0.001529785,0.0002441654,0.0006529515,0.00006360452,0.00006246037,0.0003347726,0.002590014,0.0001661323,0.001913279,0.01800617],"study_design_scores_gemma":[0.9311024,0.06192107,0.004066207,0.00003990614,0.0003595363,0.00006812395,0.00002173905,0.0002117685,0.0002455379,0.0001754806,0.001774301,0.00001398324],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851372,0.004706487,0.0003363606,0.001883344,0.0004175004,0.002305524,0.001686559,0.00008356031,0.003443474],"genre_scores_gemma":[0.9873592,0.001562542,0.0009357449,0.002060156,0.0004303139,0.002462008,0.001694017,0.00001716148,0.003478911],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005080847,"threshold_uncertainty_score":0.01699716,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01511151638438078,"score_gpt":0.2572424225864546,"score_spread":0.2421309062020738,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}